Upregulation of TRAIL-R2 is not involved in HDACi mediated sensitization to TRAIL-induced apoptosis

被引:0
|
作者
S Inoue
D Twiddy
M J S Dyer
G M Cohen
机构
[1] MRC Toxicology Unit,
[2] Hodgkin Building,undefined
[3] University of Leicester,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2160 / 2162
页数:2
相关论文
共 50 条
  • [21] Differing molecular mechanisms involved in the sensitization of human renal cancer cells to TRAIL-induced apoptosis
    Brooks, Alan D.
    Thompson, Candace R.
    Pompei, Richard J.
    Booth, Nancy
    Gustafson, Kirk R.
    Henrich, Curtis J.
    McMahon, James B.
    Sayers, Thomas J.
    CANCER RESEARCH, 2011, 71
  • [22] Histone deacetylase inhibitor-mediated sensitization to TRAIL-induced apoptosis in childhood malignancies is not associated with upregulation of TRAIL receptor expression, but with potentiated caspase-8 activation
    Sonnemann, Juergen
    Trommer, Navina
    Becker, Sabine
    Wittig, Susan
    Grauel, Desiree
    Palani, Chithra D.
    Beck, James F.
    CANCER BIOLOGY & THERAPY, 2012, 13 (06) : 417 - 424
  • [23] Bortezomib-mediated up-regulation of TRAIL-R1 and TRAIL-R2 is not necessary for but contributes to sensitization of primary human glioma cells to TRAIL
    Koschny, Ronald
    Sykora, Jaromir
    Walczak, Henning
    Ganten, Tom M.
    Haas, Tobias L.
    Sprick, Martin R.
    Holland, Heidrum
    Ahnert, Peter
    Krupp, Wolfgang
    Meixensberger, Juergen
    Bauer, Manfred
    CLINICAL CANCER RESEARCH, 2007, 13 (21) : 6541 - 6542
  • [24] N-glycosylation of mouse TRAIL-R restrains TRAIL-induced apoptosis
    Yann Estornes
    Yves Dondelinger
    Kathrin Weber
    Inge Bruggeman
    Adam Peall
    Marion MacFarlane
    Serge Lebecque
    Peter Vandenabeele
    Mathieu J. M. Bertrand
    Cell Death & Disease, 9
  • [25] N-glycosylation of mouse TRAIL-R restrains TRAIL-induced apoptosis
    Estornes, Yann
    Dondelinger, Yves
    Weber, Kathrin
    Bruggeman, Inge
    Peall, Adam
    MacFarlane, Marion
    Lebecque, Serge
    Vandenabeele, Peter
    Bertrand, Mathieu J. M.
    CELL DEATH & DISEASE, 2018, 9
  • [26] Sensitization of renal carcinoma cells to TRAIL-induced apoptosis by rocaglamide and analogs
    Nalli, Ancy D.
    Brown, Lauren E.
    Thomas, Cheryl L.
    Sayers, Thomas J.
    Porco, John A., Jr.
    Henrich, Curtis J.
    SCIENTIFIC REPORTS, 2018, 8
  • [27] Sensitization of chronic lymphocytic leukemia cells to TRAIL-induced apoptosis by hyperthermia
    Moulin, Maryline
    Dumontet, Charles
    Arrigo, Andre-Patrick
    CANCER LETTERS, 2007, 250 (01) : 117 - 127
  • [28] Tunicamycin sensitizes human prostate cells to TRAIL-induced apoptosis by upregulation of TRAIL receptors and downregulation of cIAF2
    Jung, Young-Hwa
    Lim, Eun Jin
    Heo, Jeonghoon
    Kwon, Taeg Kyu
    Kim, Young-Ho
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 40 (06) : 1941 - 1948
  • [29] Sensitization of renal carcinoma cells to TRAIL-induced apoptosis by rocaglamide and analogs
    Ancy D. Nalli
    Lauren E. Brown
    Cheryl L. Thomas
    Thomas J. Sayers
    John A. Porco
    Curtis J. Henrich
    Scientific Reports, 8
  • [30] TRAIL-induced survival and proliferation of SCLC cells is mediated by ERK and dependent on TRAIL-R2/DR5 expression in the absence of caspase-8
    Belyanskaya, Larisa L.
    Ziogas, Algirdas
    Ns-Donaldson, Sally Hopki
    Kurtz, Stefanie
    Simon, Hans-Uwe
    Stahel, Rolf
    Zangemeister-Wittke, Uwe
    LUNG CANCER, 2008, 60 (03) : 355 - 365